About Strand Life Sciences
Strand Life Sciences is a Healthcare company based in Bengaluru (India) founded in 2000 by Vinay V, Ramesh Hariharan, and Vijay Chandru, and was acquired by Reliance Industries in September 2021. Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery. Strand Life Sciences has raised $34.88 million across 9 funding rounds from investors including HCG, Syngene and WestBridge Capital. The company has 1,663 employees. Strand Life Sciences was last valued at $47.67 million in February 2018. Its chief executive, as recorded, is Ramesh Hariharan. Its website strandls.com draws about 15 thousand monthly visits. Its Indian entity Strand Life Sciences Private Limited reported revenue of ₹124 Cr. Its focus areas include Life Sciences, Genomics, Genomics Services and Bioinformatics.
Company details
Strand Life Sciences was founded in 2000 in Bengaluru, India, within the biotechnology sector. Omics-based solutions are delivered for clinical genomics, systems biology, and drug discovery. Sequence-based diagnostics and clinical genomic data interpretation services are supplied to healthcare establishments. Integrated omics analysis, image management, systems biology modeling, and molecular modeling tools are also made available to support research and development operations.
- Headquarters Bengaluru, India
- Employees 1,663
- Founders Vinay V, Ramesh Hariharan, Vijay Chandru
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website strandls.com
- Social LinkedIn X Facebook
- Acquired by Reliance Industries (Sep 2021)
- Legal Name Strand Life Sciences Private Limited
- Date of Incorporation 06 Oct, 2000
- Jurisdiction Bangalore, Karnataka, India
- Annual Revenue₹124 Cr
FY 2026 · +3% YoY
- Net Loss-₹27.76 Cr
FY 2026 · -23% margin
- EBITDA-₹26.56 Cr
FY 2026 · -22% margin
- Total Equity Funding$34.88M (USD)
in 9 rounds
- Latest Funding Round$13.84M (USD), Series C
Feb 2018
- InvestorsHCG
& 28 more
- Employee Count1,663
- Acquired by
Associated legal entities of Strand Life Sciences
Strand Life Sciences operates through Strand Life Sciences Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Strand Life Sciences Private Limited CIN U85199KA2000PTC027913 | Active | 06 Oct 2000 | Bangalore, Karnataka | ₹124 Cr | 428 | 9 | View details |
Funding Insights of Strand Life Sciences
Strand Life Sciences has successfully raised a total of $34.88M across 9 strategic funding rounds. The most recent funding activity was a Series C round of $13.84 million completed in February 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $34.88M
- Total Rounds 9
- Last Round Series C — $13.84M
- First Round $2M
(Jun 2000)
- Investors Count 27
All 9 funding rounds of Strand Life Sciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2018 | $13.84M | Series C | $47.67M | Quadria Capital | |
| Jun 2016 | Series B | – | – | – | |
| Dec 2014 | $4.86M | Series B | $39M | Biomark Capital | |
| Feb 2013 | $11.18M | Series B | $••••• | Biomark Capital, Burrill and Company | – |
| Mar 2012 | Angel Round | $••••• | Francois Mandeville | – | |
| Mar 2011 | Angel Round | $••••• | Francois Mandeville | ||
| Sep 2010 | Angel Round | $••••• | Vikrant Patil, Sumathy K | – | |
| Jun 2002 | $5M | Series A | – | WestBridge Capital, Ascent Capital | – |
| Jun 2000 | $2M | Grant | – | – | – |
| Date | Valuation | Stage |
|---|---|---|
| Feb 2018 | $47.67M | •••••••• |
| Dec 2014 | $39M | •••••••• |
| Feb 2013 | $••••• | •••••••• |
Full valuation and stage history of Strand Life Sciences
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $47.67M (Feb 2018). 29 investors in total: 13 institutional and 16 angel.
Investors in Strand Life Sciences
Strand Life Sciences has secured backing from 29 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include HCG, Syngene and WestBridge Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Healthcare private equity investments focused on Asian markets. | 2012 | quadriacapital.com | Singapore, Singapore | |
Healthcare investment fund focused on innovation and social impact in India. | 2016 | healthquad.in | Delhi, India | |
Private equity and venture capital investment firm | heritascapital.com | Singapore, Singapore | ||
Stage agnostic VC firm investing majorly in North America | biomarkcapital.com | San Francisco, United States | ||
Financial services involving loans against assets and corporate financing in India. | 2019 | infina.co.in | Mumbai, India | |
Investment firm focusing on purpose-driven capital for Indian entrepreneurs in sectors like financial services and technology. | 2000 | westbridgecap.com | Quatre Bornes, Mauritius | |
AscentCapital is engaged in potato farming, grain marketing, and equipment services in Maine. | 2000 | ascentcapital.in | Bengaluru, India | |
Chain of oncology hospitals | 1989 | hcgoncology.com | Bengaluru, India | |
| hcgel.com | ||||
Multi-category products are listed on an online B2B platform. | 1994 | burrillandco.com | Wuxi, China |
Investor details for Strand Life Sciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Strand Life Sciences Private Limited (Strand Life Sciences)
Strand Life Sciences Private Limited is the primary company behind Strand Life Sciences. The board of Strand Life Sciences Private Limited currently have 6 directors; the longest-serving is Vijaya Chandru, appointed in 2000. 18 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijaya Chandru DIN 00914988 | Director | 23 Oct 2000 | 26 yrs | Strand Life Sciences Private Limited |
| Ramesh Hariharan DIN 05103194 | Whole-time director | 01 Oct 2011 | 15 yrs 1 mo | Strand Life Sciences Private Limited |
| Nikhil K S Chakrapani DIN 03585055 | Director | 07 Jan 2022 | 4 yrs 10 mo | Strand Life Sciences Private Limited |
| Nilesh Pramodkumar Modi DIN 09460046 | Director | 07 Jan 2022 | 4 yrs 10 mo | Strand Life Sciences Private Limited |
| Rahul Yogendra Dutt DIN 08872616 | Director | 19 Jan 2022 | 4 yrs 9 mo | Strand Life Sciences Private Limited |
| Achuthan Siddharth DIN 00016278 | Director | 19 Feb 2022 | 4 yrs 8 mo | Strand Life Sciences Private Limited |
People of Strand Life Sciences
115 people are tracked at Strand Life Sciences (28 in leadership, 87 in team); the tracked headcount is 1,663.
| Name | Role | Group |
|---|---|---|
Vinay V | Co-Founder | Leadership |
| Co-Founder & CEO & CTO | Leadership | |
Vijay Chandru | Co-Founder & Director | Leadership |
Jemima Jacob | Senior Director Solutions | Leadership |
Ajay Kumar K. S | Director - Solutions | Leadership |
Sameer Phalke | Director Laboratory Sciences | Leadership |
Ruchi Singh | Manager Human Resources Business Partner | Leadership |
Ramesh Srinivasan | Director - International Markets | Leadership |
Nimisha Kulshreshtha | Head Of Marketing - Clinical | Leadership |
George Varghese | Vice President - Operations | Leadership |
Ashok Gopinath | Partner Development Head | Leadership |
Arvind Pachhapur | Chief Commercial Officer | Leadership |
Vamsi Veeramachaneni | Chief Scientific Officer | Leadership |
Anand Janakiraman | President, Bioinformatics | Leadership |
Nivesh Kumar | Director Commercial Research | Leadership |
Aditi Chatterjee | Head, Clinical Research | Leadership |
Santosh Kumar Gouda 🇮🇳 | Director Sales Oncology Business | Leadership |
Mousumi K. | Senior Manager - Human Resources Business Partner | Leadership |
Sanjay Mahendra | Vice President - Clinical Business | Leadership |
Pallavi Ghana | Director Project Management | Leadership |
95 more people are available in the full profile.
Complete people profiles for Strand Life Sciences
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Strand Life Sciences
Figures of Strand Life Sciences Private Limited, the primary company behind Strand Life Sciences, for FY 2026. Revenue was ₹124 Cr (+3% year on year). Net loss was -₹27.76 Cr (-23% margin). EBITDA was -₹26.56 Cr (-22% margin). Revenue has grown at a compounded annual rate of +12% over three years and +7% over five years.
- ₹124 CrRevenue · FY 2026 · +3% YoY
- -₹27.76 CrNet loss · -23% margin
- -₹26.56 CrEBITDA · -22% margin
- ₹24.39 CrPaid-up capital
- 428Employees (provident fund records)
- +12%Revenue CAGR, 3 years
- +7%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Strand Life Sciences Private Limited are on its company page.
Detailed financial statements for Strand Life Sciences
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Strand Life Sciences
6 dated milestones of Strand Life Sciences across 21 years, from founding to its latest funding, stage changes and deals.
- Founded Strand Life Sciences is founded.
- Funding First funding round of $2.0M.
- Milestone Reaches Minicorn status.
- Exit Acquired by Syngene.
- Funding Latest funding round, Series C, of $13.8M.
- Exit Acquired by Reliance Industries.
Web traffic of Strand Life Sciences
The website of Strand Life Sciences (strandls.com) receives about 15.1K visits a month and ranks #1,397,168 among all websites worldwide, #1,809 in Biotechnology and Pharmaceuticals.
- Monthly visits15.1K
▼ 25.8% vs previous month
- Unique visitors9.5K
per month
- Global rank#1,397,168
among all websites
- Category rank#1,809
Health · Biotechnology and Pharmaceuticals
- Bounce rate62%
- Pages per visit1.6
- Average visit27 sec
- DevicesDesktop 24% · Mobile 76%
Websites whose visitors overlap most with Strand Life Sciences. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
en.wikipedia.org | en.wikipedia.org | 100% | – | ||
hariharan-ramesh.com | hariharan-ramesh.com | 97% | #14,870,401 | – | |
| meta-helix.com | 96% | View details | |||
| arraygen.com | 78% | 3.4K | #5,808,113 | View details | |
| strands.com | 70% | 12.4K | #2,031,295 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for Strand Life Sciences
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Strand Life Sciences
Complete news archive for Strand Life Sciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Strand Life Sciences
Strand Life Sciences was founded in 2000.
Strand Life Sciences is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.
Ramesh Hariharan is the CEO of Strand Life Sciences, as recorded in our data. They have also founded this company.
Strand Life Sciences is a funded company, having raised a total of $34.88M across 9 funding rounds to date. The company's 1st funding round was a Grant of $2M, raised on Jun 2000.
Strand Life Sciences has 1,663 employees.
The primary company behind Strand Life Sciences, Strand Life Sciences Private Limited, reported revenue of ₹124 Cr for FY 2026, up 3% year on year.
Strand Life Sciences was founded in 2000 in Bengaluru, India, within the biotechnology sector. Omics-based solutions are delivered for clinical genomics, systems biology, and drug discovery. Sequence-based diagnostics and clinical genomic data interpretation services are supplied to healthcare establishments. Integrated omics analysis, image management, systems biology modeling, and molecular modeling tools are also made available to support research and development operations.
Strand Life Sciences has 29 investors. Key investors include HCG, Syngene, WestBridge Capital, Quadria Capital, and HealthQuad.
The valuation of Strand Life Sciences is $47.67M as of Feb 2018.
Strand Life Sciences operates through Strand Life Sciences Private Limited.
Yes. Strand Life Sciences was acquired by Reliance Industries in September 2021.
The legal entities of Strand Life Sciences currently have 8 directors, including Nikhil K S Chakrapani, Nilesh Pramodkumar Modi, Rahul Yogendra Dutt and others.